HEALTHCARE REALTY TRUST INC (HR) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:HR • US42226K1051

17.385 USD
+0.03 (+0.14%)
Last: Feb 11, 2026, 02:12 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

HR gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 122 industry peers in the Diversified REITs industry. HR may be in some trouble as it scores bad on both profitability and health. HR is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • HR had negative earnings in the past year.
  • In the past year HR had a positive cash flow from operations.
  • In multiple years HR reported negative net income over the last 5 years.
  • HR had a positive operating cash flow in each of the past 5 years.
HR Yearly Net Income VS EBIT VS OCF VS FCFHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B -1.5B -2B

1.2 Ratios

  • With a Return On Assets value of -3.76%, HR is not doing good in the industry: 78.69% of the companies in the same industry are doing better.
  • HR has a worse Return On Equity (-7.91%) than 72.95% of its industry peers.
  • The Return On Invested Capital of HR (0.51%) is worse than 83.61% of its industry peers.
  • HR had an Average Return On Invested Capital over the past 3 years of 0.38%. This is below the industry average of 3.07%.
  • The last Return On Invested Capital (0.51%) for HR is above the 3 year average (0.38%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -3.76%
ROE -7.91%
ROIC 0.51%
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
HR Yearly ROA, ROE, ROICHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10

1.3 Margins

  • With a Operating Margin value of 5.10%, HR is not doing good in the industry: 82.79% of the companies in the same industry are doing better.
  • In the last couple of years the Operating Margin of HR has declined.
  • The Gross Margin of HR (62.40%) is worse than 62.30% of its industry peers.
  • In the last couple of years the Gross Margin of HR has declined.
Industry RankSector Rank
OM 5.1%
PM (TTM) N/A
GM 62.4%
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
HR Yearly Profit, Operating, Gross MarginsHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HR is destroying value.
  • Compared to 1 year ago, HR has less shares outstanding
  • Compared to 5 years ago, HR has more shares outstanding
  • Compared to 1 year ago, HR has a worse debt to assets ratio.
HR Yearly Shares OutstandingHR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
HR Yearly Total Debt VS Total AssetsHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.2 Solvency

  • HR has an Altman-Z score of 0.18. This is a bad value and indicates that HR is not financially healthy and even has some risk of bankruptcy.
  • The Altman-Z score of HR (0.18) is worse than 68.03% of its industry peers.
  • The Debt to FCF ratio of HR is 36.37, which is on the high side as it means it would take HR, 36.37 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 36.37, HR is in the better half of the industry, outperforming 74.59% of the companies in the same industry.
  • A Debt/Equity ratio of 0.97 indicates that HR is somewhat dependend on debt financing.
  • The Debt to Equity ratio of HR (0.97) is better than 63.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 36.37
Altman-Z 0.18
ROIC/WACC0.08
WACC6.44%
HR Yearly LT Debt VS Equity VS FCFHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 0.13 indicates that HR may have some problems paying its short term obligations.
  • The Current ratio of HR (0.13) is worse than 94.26% of its industry peers.
  • HR has a Quick Ratio of 0.13. This is a bad value and indicates that HR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.13, HR is not doing good in the industry: 94.26% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
HR Yearly Current Assets VS Current LiabilitesHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. Growth

3.1 Past

  • The earnings per share for HR have decreased strongly by -15.22% in the last year.
  • Looking at the last year, HR shows a very negative growth in Revenue. The Revenue has decreased by -25.49% in the last year.
  • Measured over the past years, HR shows a quite strong growth in Revenue. The Revenue has been growing by 12.88% on average per year.
EPS 1Y (TTM)-15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.62%
Revenue 1Y (TTM)-25.49%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-5.6%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.88% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, HR will show a decrease in Revenue. The Revenue will decrease by -1.33% on average per year.
EPS Next Y32.5%
EPS Next 2Y36.73%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue Next Year-6.37%
Revenue Next 2Y-3.8%
Revenue Next 3Y-1.55%
Revenue Next 5Y-1.33%

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HR Yearly Revenue VS EstimatesHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
HR Yearly EPS VS EstimatesHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 -1 -1.5

More info and screens

Find the best growth stocksShow best growing peers

2

4. Valuation

4.1 Price/Earnings Ratio

  • HR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for HR. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
HR Price Earnings VS Forward Price EarningsHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • HR's Enterprise Value to EBITDA ratio is in line with the industry average.
  • HR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. HR is cheaper than 69.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 48.78
EV/EBITDA 16.13
HR Per share dataHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as HR's earnings are expected to grow with 23.88% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.73%
EPS Next 3Y23.88%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

6

5. Dividend

5.1 Amount

  • HR has a Yearly Dividend Yield of 6.58%, which is a nice return.
  • HR's Dividend Yield is a higher than the industry average which is at 6.81.
  • Compared to an average S&P500 Dividend Yield of 1.80, HR pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.58%

5.2 History

  • The dividend of HR has a limited annual growth rate of 0.57%.
  • HR has paid a dividend for at least 10 years, which is a reliable track record.
  • HR has decreased its dividend recently.
Dividend Growth(5Y)0.57%
Div Incr Years0
Div Non Decr Years1
HR Yearly Dividends per shareHR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

  • HR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
  • The dividend of HR is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-111.25%
EPS Next 2Y36.73%
EPS Next 3Y23.88%
HR Yearly Income VS Free CF VS DividendHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B -2B

More info and screens

Find the best dividend stocksShow peers with best dividend

HEALTHCARE REALTY TRUST INC

NYSE:HR (2/11/2026, 2:12:00 PM)

17.385

+0.03 (+0.14%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-30
Earnings (Next)02-12
Inst Owners114.51%
Inst Owner Change-2.02%
Ins Owners0.57%
Ins Owner Change-0.55%
Market Cap6.11B
Revenue(TTM)1.20B
Net Income(TTM)-370.62M
Analysts74
Price Target19.38 (11.48%)
Short Float %5.25%
Short Ratio6.16
Dividend
Industry RankSector Rank
Dividend Yield 6.58%
Yearly Dividend1.25
Dividend Growth(5Y)0.57%
DP-111.25%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-343.81%
Min EPS beat(2)-446.12%
Max EPS beat(2)-241.5%
EPS beat(4)0
Avg EPS beat(4)-254.5%
Min EPS beat(4)-446.12%
Max EPS beat(4)-40.24%
EPS beat(8)1
Avg EPS beat(8)-216.28%
EPS beat(12)1
Avg EPS beat(12)-161.8%
EPS beat(16)3
Avg EPS beat(16)-58.3%
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-1.59%
Max Revenue beat(2)-1.38%
Revenue beat(4)0
Avg Revenue beat(4)-1.61%
Min Revenue beat(4)-2.27%
Max Revenue beat(4)-1.18%
Revenue beat(8)1
Avg Revenue beat(8)-1.47%
Revenue beat(12)1
Avg Revenue beat(12)-1.38%
Revenue beat(16)2
Avg Revenue beat(16)2.7%
PT rev (1m)-2.56%
PT rev (3m)0%
EPS NQ rev (1m)40%
EPS NQ rev (3m)76%
EPS NY rev (1m)-32.76%
EPS NY rev (3m)-42.99%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)-0.57%
Revenue NY rev (1m)0.33%
Revenue NY rev (3m)0.33%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.08
P/FCF 48.78
P/OCF 13.21
P/B 1.31
P/tB 1.31
EV/EBITDA 16.13
EPS(TTM)-1.06
EYN/A
EPS(NY)-0.15
Fwd EYN/A
FCF(TTM)0.36
FCFY2.05%
OCF(TTM)1.32
OCFY7.57%
SpS3.42
BVpS13.32
TBVpS13.32
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -3.76%
ROE -7.91%
ROCE 0.64%
ROIC 0.51%
ROICexc 0.51%
ROICexgc 0.54%
OM 5.1%
PM (TTM) N/A
GM 62.4%
FCFM 10.41%
ROA(3y)-2.72%
ROA(5y)-1.19%
ROE(3y)-5.41%
ROE(5y)-2.31%
ROIC(3y)0.38%
ROIC(5y)1.07%
ROICexc(3y)0.38%
ROICexc(5y)1.09%
ROICexgc(3y)0.39%
ROICexgc(5y)1.1%
ROCE(3y)0.48%
ROCE(5y)1.36%
ROICexgc growth 3Y-49.37%
ROICexgc growth 5Y-31.73%
ROICexc growth 3Y-49.34%
ROICexc growth 5Y-31.78%
OM growth 3Y-49.95%
OM growth 5Y-33.08%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y-2.03%
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 36.37
Debt/EBITDA 6.92
Cap/Depr 56.54%
Cap/Sales 28.03%
Interest Coverage 0.33
Cash Conversion 70.3%
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z 0.18
F-Score5
WACC6.44%
ROIC/WACC0.08
Cap/Depr(3y)74.85%
Cap/Depr(5y)98.72%
Cap/Sales(3y)37.95%
Cap/Sales(5y)42.97%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-15.22%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%34.62%
EPS Next Y32.5%
EPS Next 2Y36.73%
EPS Next 3Y23.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-25.49%
Revenue growth 3Y18.25%
Revenue growth 5Y12.88%
Sales Q2Q%-5.6%
Revenue Next Year-6.37%
Revenue Next 2Y-3.8%
Revenue Next 3Y-1.55%
Revenue Next 5Y-1.33%
EBIT growth 1Y-2.63%
EBIT growth 3Y-40.82%
EBIT growth 5Y-24.46%
EBIT Next Year1168.33%
EBIT Next 3Y136%
EBIT Next 5Y91.35%
FCF growth 1Y-26.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.75%
OCF growth 3Y9.16%
OCF growth 5Y8.06%

HEALTHCARE REALTY TRUST INC / HR FAQ

What is the ChartMill fundamental rating of HEALTHCARE REALTY TRUST INC (HR) stock?

ChartMill assigns a fundamental rating of 3 / 10 to HR.


Can you provide the valuation status for HEALTHCARE REALTY TRUST INC?

ChartMill assigns a valuation rating of 2 / 10 to HEALTHCARE REALTY TRUST INC (HR). This can be considered as Overvalued.


Can you provide the profitability details for HEALTHCARE REALTY TRUST INC?

HEALTHCARE REALTY TRUST INC (HR) has a profitability rating of 2 / 10.


How sustainable is the dividend of HEALTHCARE REALTY TRUST INC (HR) stock?

The dividend rating of HEALTHCARE REALTY TRUST INC (HR) is 6 / 10 and the dividend payout ratio is -111.25%.